Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Susumu Takeuchi

Showing results (61-70 of 64) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 64 results.
Frontiers in Immunology|August 29, 2024
IgA vasculitis induced by carboplatin + nab-paclitaxel + pembrolizumab in a patient with advanced lung squamous cell carcinoma: a case reportYuto Terashima, Masaru Matsumoto, Saeko Ozaki, et al.
Cancer Science|November 30, 2021
Alpha-actinin-4 (ACTN4) gene amplification is a predictive biomarker for adjuvant chemotherapy with tegafur/uracil in stage I lung adenocarcinomasRintaro Noro, Kazufumi Honda, Kengo Nagashima, et al.
International Journal of Clinical Oncology|October 13, 2021
Osimertinib in poor performance status patients with T790M-positive advanced non-small-cell lung cancer after progression of first- and second-generation EGFR-TKI treatments (NEJ032B)Yukari Tsubata, Kana Watanabe, Ryota Saito, et al.
International Journal of Clinical Oncology|March 8, 2022
Correction to: Osimertinib in poor performance status patients with T790M‑positive advanced non‑small‑cell lung cancer after progression of first- and second‑generation EGFR‑TKI treatments (NEJ032B)Yukari Tsubata, Kana Watanabe, Ryota Saito, et al.
Pageof 7

Showing results (61-70 of 64) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 64 results.
Frontiers in Immunology|August 29, 2024
IgA vasculitis induced by carboplatin + nab-paclitaxel + pembrolizumab in a patient with advanced lung squamous cell carcinoma: a case reportYuto Terashima, Masaru Matsumoto, Saeko Ozaki, et al.
Cancer Science|November 30, 2021
Alpha-actinin-4 (ACTN4) gene amplification is a predictive biomarker for adjuvant chemotherapy with tegafur/uracil in stage I lung adenocarcinomasRintaro Noro, Kazufumi Honda, Kengo Nagashima, et al.
International Journal of Clinical Oncology|October 13, 2021
Osimertinib in poor performance status patients with T790M-positive advanced non-small-cell lung cancer after progression of first- and second-generation EGFR-TKI treatments (NEJ032B)Yukari Tsubata, Kana Watanabe, Ryota Saito, et al.
International Journal of Clinical Oncology|March 8, 2022
Correction to: Osimertinib in poor performance status patients with T790M‑positive advanced non‑small‑cell lung cancer after progression of first- and second‑generation EGFR‑TKI treatments (NEJ032B)Yukari Tsubata, Kana Watanabe, Ryota Saito, et al.
Pageof 7